Crossmark

Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis

Published Online: 2024-11-22

Authors

Yan, Qingkai

Chen, Xinrao

Yu, Changqing

Yin, Yuehui
License Information

Text and Data Mining valid from 2024-11-22

Version of Record valid from 2024-11-22
More Information

Article History

Received: 10 July 2024

Accepted: 4 November 2024

First Online: 22 November 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

: Not applicable.

Document is current